Swedbank AB Has $30.72 Million Holdings in Ventas, Inc. $VTR

Swedbank AB lessened its position in shares of Ventas, Inc. (NYSE:VTR) by 5.1% in the third quarter, Holdings Channel.com reports. The institutional investor owned 438,929 shares of the real estate investment trust’s stock after selling 23,782 shares during the period. Swedbank AB’s holdings in Ventas were worth $30,721,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Ventas by 4.1% during the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after acquiring an additional 2,854,751 shares during the period. State Street Corp grew its stake in Ventas by 5.2% during the second quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock worth $1,781,267,000 after purchasing an additional 1,388,678 shares during the period. Geode Capital Management LLC increased its holdings in Ventas by 4.9% in the second quarter. Geode Capital Management LLC now owns 12,226,283 shares of the real estate investment trust’s stock worth $769,061,000 after purchasing an additional 574,663 shares in the last quarter. Resolution Capital Ltd increased its holdings in Ventas by 10.5% in the first quarter. Resolution Capital Ltd now owns 7,889,848 shares of the real estate investment trust’s stock worth $542,506,000 after purchasing an additional 751,587 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in Ventas by 6.3% in the second quarter. Charles Schwab Investment Management Inc. now owns 5,597,778 shares of the real estate investment trust’s stock valued at $353,500,000 after buying an additional 331,477 shares during the period. Institutional investors own 94.18% of the company’s stock.

Insider Activity at Ventas

In other Ventas news, CEO Debra A. Cafaro sold 317,258 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $74.24, for a total transaction of $23,553,233.92. Following the transaction, the chief executive officer directly owned 1,145,695 shares in the company, valued at approximately $85,056,396.80. This trade represents a 21.69% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Robert F. Probst sold 33,591 shares of Ventas stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $76.77, for a total transaction of $2,578,781.07. Following the transaction, the chief financial officer directly owned 168,364 shares in the company, valued at $12,925,304.28. This represents a 16.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 688,184 shares of company stock valued at $50,726,248 over the last 90 days. Insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Wells Fargo & Company raised their price objective on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Evercore ISI raised their price target on shares of Ventas from $77.00 to $80.00 and gave the stock an “outperform” rating in a report on Monday, September 15th. UBS Group began coverage on shares of Ventas in a research note on Friday, September 19th. They issued a “neutral” rating and a $73.00 price target for the company. Scotiabank increased their price objective on shares of Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. Finally, Cantor Fitzgerald raised their target price on Ventas from $77.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $79.31.

Ventas Stock Up 0.6%

Shares of NYSE VTR opened at $79.62 on Friday. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.32 and a quick ratio of 0.32. The company has a 50-day moving average price of $76.94 and a 200-day moving average price of $70.24. The stock has a market capitalization of $37.40 billion, a P/E ratio of 153.12, a P/E/G ratio of 2.01 and a beta of 0.78. Ventas, Inc. has a 1 year low of $56.68 and a 1 year high of $81.89.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.01. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.44 billion. Ventas had a net margin of 4.28% and a return on equity of 2.05%. The firm’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.80 EPS. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. On average, equities research analysts forecast that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be given a dividend of $0.48 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $1.92 annualized dividend and a dividend yield of 2.4%. Ventas’s payout ratio is presently 369.23%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.